We first study our clients thoroughly and then advice on how they can best leverage on the opportunity… Global Cancer Drug Market was valued at USD 73.41 Billion in the year 2017. Global Cancer Drug market is further estimated to grow at a CAGR of 7.98% from 2018 to 2023 to reach USD 116.39 Billion by the year 2023. North America region holds the highest market share in 2016 with APAC region is considered as the fastest growing market in the forecasted period. At a country level, the U.S is the biggest market in 2016 and it is projected to grow at a gradual pace in the coming years. Roche Diagnostics (Switzerland), Celgene (U.S), Johnson & Johnson (U.S) and Novartis (Switzerland) are some of the key manufacturers in the Global Blood Screening market. From all the key players Roche Diagnostics holds the substantial market share because of its better global presence both at production and at an operational level. Rising research and development expenses to cater changing demand of end users, similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years. Download Free Report Sample @…